Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06145724 · ClinicalTrials.gov registry record · NA

EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)

A NA study of Infections and Maternal Sepsis, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
33,183
Enrollment target
4
Study locations

NCT06145724 is a NA study of Infections and Maternal Sepsis that is actively recruiting participants, run by Columbia University. The registered enrollment target is 33,183 participants, above the 2,131-participant average among 26 other Infections trials with a reported enrollment target (1457% higher). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06145724, a NA study of Infections and Maternal Sepsis, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
33,183 participants
Enrollment target
4
Study locations

Study Summary

Sepsis is the second leading cause of maternal death in the U.S. Labor and postpartum are particularly vulnerable risk periods. The goal of this multi-center, multidisciplinary study is to evaluate a maternal sepsis safety bundle.

Interventions

  • BEHAVIORAL Maternal Sepsis Safety Bundle

Study Locations (4)

New York

  • Columbia Unviersity Irving Medical Center - New York
  • NewYork-Presbyterian Allen Hospital - New York
  • NYC Health+Hospitals/Harlem - New York
  • NYC Health + Hospitals/Lincoln - The Bronx

Trial Details

FieldValue
Enrollment Target 33,183 participants
Start Date 2025-06-01
Est. Completion 2026-09-20
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT06145724

The ClinicalTrials.gov registry entry for NCT06145724 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 33,183 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,131-participant average among 26 other Infections trials with a reported enrollment target (1457% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Infections appearing as the primary indexed condition, and to 1 intervention - of which Maternal Sepsis Safety Bundle is the first listed.

NCT06145724 reports 4 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06145724 about?

NCT06145724 is a clinical study titled "EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)". Sepsis is the second leading cause of maternal death in the U.S. Labor and postpartum are particularly vulnerable risk periods. The goal of this multi-center, multidisciplinary study is to evaluate a maternal sepsis safety bundle.

What is the current status of trial NCT06145724?

This trial is currently recruiting. It is a NA study. The enrollment target is 33,183 participants. The study started on 2025-06-01. Estimated completion is 2026-09-20.

What conditions does trial NCT06145724 study?

This clinical trial studies the following conditions: Infections, Maternal Sepsis.

What interventions are being tested in trial NCT06145724?

The interventions under investigation include: Maternal Sepsis Safety Bundle (BEHAVIORAL).

Who is sponsoring clinical trial NCT06145724?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06145724 being conducted?

This trial has 4 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.